Form 4: HCA Healthcare EVP and CFO Mike Marks Acquires Stock Appreciation Rights
SEC Form 4 Filing
HCA Healthcare's EVP and CFO, Mike Marks, was granted 15,639 stock appreciation rights on January 28, 2025, which vest in four equal annual installments starting January 28, 2026.
Summary
- Mike Marks, the Executive Vice President and Chief Financial Officer of HCA Healthcare, Inc., acquired 15,639 stock appreciation rights on January 28, 2025.
- These rights are derivative securities that will allow Mr. Marks to benefit from any increase in the price of HCA's common stock.
- The stock appreciation rights vest in four equal annual installments, beginning on January 28, 2026.
- The rights expire on January 28, 2035.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no indications of negative sentiment.
Positives
- The granting of stock appreciation rights to a key executive like the CFO can be seen as a positive sign, aligning his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Risks
- The value of the stock appreciation rights is dependent on the future performance of HCA's stock price, which is subject to market risks.
- There is a risk that the stock price may not increase sufficiently for the rights to be valuable.
Future Outlook
The value of the stock appreciation rights will depend on the future performance of HCA's stock price.
Industry Context
This type of equity-based compensation is common for executives in publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation.
Comparison to Industry Standards
- Stock appreciation rights are a common form of executive compensation in the healthcare industry, similar to grants at companies like Tenet Healthcare and Universal Health Services.
- The vesting schedule of four equal annual installments is also a standard practice to ensure long-term alignment.
Stakeholder Impact
- Shareholders may view this as a positive sign, as it aligns the CFO's interests with the company's long-term performance.
- Employees may see this as a sign of stability and commitment from the executive team.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of the transaction where Mike Marks acquired stock appreciation rights. |
| 01/28/2026 | First vesting date for the stock appreciation rights. |
| 01/28/2035 | Expiration date of the stock appreciation rights. |
| 01/30/2025 | Date the form was signed. |
Keywords
Stock Appreciation Rights, HCA Healthcare, Executive Compensation, Mike Marks, Derivative Securities, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.